Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
41.94
-1.84 (-4.20%)
At close: Mar 9, 2026

Shandong Keyuan Pharmaceutical Company Description

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations.

It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofenac; chlorzoxazone; esomeprazole sodium; palonosetron hydrochloride; dalafeng; piroxicam; phenylephrine; vildagliptin; parecoxib sodium; ruxolitinib hydrochloride; and lurasidone hydrochloride.

The company was founded in 2004 and is headquartered in Jinan, China.

Shandong Keyuan Pharmaceutical Co., Ltd.
Country China
Founded 2004
Industry Drug Manufacturers - General
Sector Healthcare
Employees 696
CEO Chun Po Gao

Contact Details

Address:
Keyuan Street
Jinan, 251601
China
Phone 86 531 8872 9285
Website keyuanpharm.com

Stock Details

Ticker Symbol 301281
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE1000061V8
SIC Code 2834

Key Executives

Name Position
Chun Po Gao GM and Chairman
Chun Hua Li Deputy GM, Chief Financial Officer, Accounting Supervisor and Secretary of the Board